Renewable Standard Reference Material for the Detection of TP53 Mutations
Molecular Diagnosis · 2003
DOI: 10.1007/bf03260024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diagnosis, 2003. Verfasst von Catherine D O'Connell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA. coc@nist.gov. Hauptthemen laut MEDLINE: Genes, p53, Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Numerous DNA-based tests are currently in use or under development for the detection of mutations associated with disease. Most of the current methods use PCR amplification technologies and detection after separation or chromatography of the products. We have developed a panel of standard reference materials consisting of 12 plasmid clones containing a 2.0 kb region of the TP53 gene, including exons 5-9. Eleven of these clones contain a single mutation within the mutational hot spots of the TP53 gene, the twelfth is wild-type in this region of the gene. The mutations are amino acid (aa) 128: C to T; aa 175: G to A; aa 237: T to C; aa 245: G to A; aa 248: C to T; aa 248: G to A; aa 249: G to T; aa 273: C to T; aa 273: G to A; aa 282: C to T; and aa 328: T to C. These standard reference materials (SRMs), created by site-directed mutagenesis of wild-type TP53 from a human cell line, include the specific mutations most commonly found to be associated with cancer. Their use will improve disease detection by serving as validation materials to monitor errors in measurement methods, including PCR amplification, amplicon separation, and data analysis from different technology platforms. METHODS AND RESULTS: The single point mutations of the panel were validated by capillary electrophoresis single-strand conformational polymorphism analysis, denaturing gradient gel electrophoresis, and denaturing high-performance liquid chromatography, as well as full sequence analysis of both DNA strands of the cloned material. For both heteroduplex analysis methods, the presence of the mutations was resolved for each SRM. CONCLUSION: The generation of a standard TP53 reference panel and demonstration that the panel can successfully validate mutation detection across different mutation scanning technology platforms. Hence, this panel functions as an SRM to normalize results obtained from different laboratories using different techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biotechnology Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA. coc@nist.gov
Zitieren
APA
O'Connell, C. D., Tully, L. A., Devaney, J. M., Marino, M. A., Jakupciak, J. P., & Atha, D. H. (2003). Renewable Standard Reference Material for the Detection of TP53 Mutations. Molecular Diagnosis. https://doi.org/10.1007/bf03260024
Vancouver
O'Connell CD, Tully LA, Devaney JM, Marino MA, Jakupciak JP, Atha DH. Renewable Standard Reference Material for the Detection of TP53 Mutations. Molecular Diagnosis. 2003. doi:10.1007/bf03260024
BibTeX
@article{OConnell2003,
author = {O'Connell, Catherine D and Tully, Lois A and Devaney, Joseph M and Marino, Michael A and Jakupciak, John P and Atha, Donald H},
title = {Renewable Standard Reference Material for the Detection of TP53 Mutations},
journal = {Molecular Diagnosis},
year = {2003},
doi = {10.1007/bf03260024}
}
EUVIMED